Panbela Therapeutics, Inc. (PBLA)
OTCMKTS
· Delayed Price · Currency is USD
0.372
-0.045 (-10.79%)
Jan 29, 2025, 4:00 PM EST
Panbela Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -27.91 | -25.26 | -34.93 | -10.14 | -4.77 | -6.2 | Upgrade
|
| Other Amortization | - | - | - | - | - | 2.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.78 | -0.4 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 17.74 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.23 | 0.82 | 1.09 | 1.29 | 1.21 | 1.09 | Upgrade
|
| Other Operating Activities | 0.59 | 0.24 | 0.27 | - | -0.1 | 0.1 | Upgrade
|
| Change in Accounts Payable | 3.49 | 7.06 | 2.25 | 0.63 | -0.75 | 0.3 | Upgrade
|
| Change in Income Taxes | -0.16 | -0.13 | 0.21 | 0.05 | -0 | -0.03 | Upgrade
|
| Change in Other Net Operating Assets | 8.97 | -7.58 | -1.9 | 0.92 | 0.56 | -0.08 | Upgrade
|
| Operating Cash Flow | -15.57 | -25.25 | -15.28 | -7.25 | -3.85 | -2.74 | Upgrade
|
| Cash Acquisitions | - | - | 0 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 0.78 | 0.4 | -0.66 | - | - | - | Upgrade
|
| Investing Cash Flow | 0.78 | 0.4 | -0.66 | - | - | - | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.1 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.82 | Upgrade
|
| Total Debt Issued | 2.2 | - | - | - | 0.1 | 0.82 | Upgrade
|
| Short-Term Debt Repaid | - | -1.65 | - | - | -0.74 | -0.03 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.12 | -0.16 | Upgrade
|
| Total Debt Repaid | -1 | -1.65 | - | - | -0.86 | -0.19 | Upgrade
|
| Net Debt Issued (Repaid) | 1.2 | -1.65 | - | - | -0.76 | 0.63 | Upgrade
|
| Issuance of Common Stock | 13.76 | 29.93 | 6.13 | 11.04 | 12.37 | 3.18 | Upgrade
|
| Repurchase of Common Stock | -0 | -0.01 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.92 | -2.12 | -0.77 | -0.95 | -1.17 | -0.02 | Upgrade
|
| Financing Cash Flow | 14.03 | 26.14 | 5.35 | 10.1 | 10.44 | 3.78 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | - | -0 | -0.01 | -0.02 | -0 | Upgrade
|
| Net Cash Flow | -0.77 | 1.29 | -10.58 | 2.85 | 6.57 | 1.04 | Upgrade
|
| Free Cash Flow | -15.57 | -25.25 | -15.28 | -7.25 | -3.85 | -2.74 | Upgrade
|
| Free Cash Flow Per Share | -4.75 | -232.30 | - | - | - | - | Upgrade
|
| Cash Interest Paid | 0.29 | 0.4 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -7.98 | -9.86 | -6.53 | -3.36 | -2.03 | -1.48 | Upgrade
|
| Unlevered Free Cash Flow | -7.58 | -9.66 | -6.35 | -3.35 | -2.02 | -2.19 | Upgrade
|
| Change in Net Working Capital | -9.56 | -5.15 | -3.44 | -1.62 | -0.37 | 0.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.